Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 6, Number 2—April 2000
Synopsis

Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases

Frederik W. van GinkelComments to Author , Huan H. Nguyen, and Jerry R. McGhee
Author affiliations: The University of Alabama at Birmingham, Birmingham, Alabama, USA

Main Article

Figure 1

M cells and the induction of mucosal immunity. M cells are present in mucosal inductive sites in both the intestinal and upper respiratory tract, specifically in Peyers patches and the nasal-associated lymphoid tissue, the tonsils and adenoids. M cells are thought to play an important role in antigen processing and possibly the induction of antigen-specific mucosal immunity in mucosal effector sites. Sites followed by question marks are presumed sites since limited data are available on these si

Figure 1. M cells and the induction of mucosal immunity. M cells are present in mucosal inductive sites in both the intestinal and upper respiratory tract, specifically in Peyers patches and the nasal-associated lymphoid tissue, the tonsils and adenoids. M cells are thought to play an important role in antigen processing and possibly the induction of antigen-specific mucosal immunity in mucosal effector sites. Sites followed by question marks are presumed sites since limited data are available on these sites.

Main Article

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external